D.E. Shaw & Co’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $122M | Buy |
|
|||||
2024
Q4 | $44.6M | Buy |
|
|||||
2024
Q3 | $27M | Sell |
|
|||||
2024
Q2 | $39.7M | Buy |
|
|||||
2024
Q1 | $27M | Sell |
|
|||||
2023
Q4 | $36.6M | Sell |
|
|||||
2023
Q3 | $38.6M | Sell |
|
|||||
2023
Q2 | $60.3M | Buy |
|
|||||
2023
Q1 | $27.6M | Sell |
|
|||||
2022
Q4 | $27.2M | Buy |
|
|||||
2022
Q3 | $16.3M | Buy |
|
|||||
2022
Q2 | $19.3M | Sell |
|
|||||
2022
Q1 | $22.3M | Buy |
|
|||||
2021
Q4 | $8.04M | Buy |
|
|||||
2021
Q3 | – | Sell |
|
|||||
2021
Q2 | $1.96M | Sell |
|
|||||
2021
Q1 | $4.07M | Buy |
|
|||||
2020
Q4 | $3.11M | Sell |
|
|||||
2020
Q3 | $5.89M | Buy |
|
|||||
2020
Q2 | $4.65M | Sell |
|
|||||
2020
Q1 | $2.87M | Sell |
|
|||||
2019
Q4 | $7.94M | Buy |
|
|||||
2019
Q3 | $1.71M | Sell |
|
|||||
2019
Q2 | $4.61M | Buy |
|
|||||
2019
Q1 | $3.8M | Buy |
|
|||||
2018
Q4 | $2.54M | Buy |
|
|||||
2018
Q3 | $4.23M | Buy |
|
|||||
2018
Q2 | $3.23M | Sell |
|
|||||
2018
Q1 | $4.68M | Buy |
|
|||||
2017
Q4 | $552K | Buy |
|
|||||
2017
Q2 | – | Sell |
|
|||||
2017
Q1 | $474K | Sell |
|
|||||
2016
Q4 | $1.79M | Buy |
|
|||||
2016
Q3 | $563K | Sell |
|
|||||
2016
Q2 | $2.66M | Buy |
|
|||||
2016
Q1 | – | Sell |
|
|||||
2015
Q4 | $678K | Sell |
|
|||||
2015
Q3 | $2.58M | Buy |
|
|||||
2015
Q2 | $1.24M | Buy |
|